{
    "medicine_id": "ea96de0c1650b129d29d0d001b6cbd2c3f1cce44",
    "platform_id": "DB00704",
    "metadata": {
        "name": "Addex 1000 1000 mg 1 Pellet implantable",
        "composition": "1000 mg 1 Naltrexone",
        "clinical_particulars": {
            "therapeutic_indications": "Used as an adjunct to a medically supervised behaviour modification program in the maintenance of opiate cessation in individuals who were formerly physically dependent on opiates and who have successfully undergone detoxification Also used for the management of alcohol dependence in conjunction with a behavioural modification program",
            "contraindications": {
                "disease": "In the mouse rat and guinea pig the oral LD sub 50 sub s were 1 100 1 550 mg kg 1 450 mg kg and 1 490 mg kg respectively High doses of naltrexone generally 1 000 mg kg produce salivation depression reduced activity tremors and convulsions",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Naltrexone a pure opioid antagonist is a synthetic congener of oxymorphone with no opioid agonist properties Naltrexone is indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids It markedly attenuates or completely blocks reversibly the subjective effects of intravenously administered opioids When co administered with morphine on a chronic basis naltrexone blocks the physical dependence to morphine heroin and other opioids In subjects physically dependent on opioids naltrexone will precipitate withdrawal symptomatology",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06274",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Alvimopan"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hyponatremia can be increased when Naltrexone is combined with Desmopressin"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of bradycardia can be increased when Succinylcholine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Naltrexone may increase the opioid antagonism activities of Methylnaltrexone"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "Naltrexone may increase the opioid antagonism activities of Naloxegol"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Naltrexone can be increased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Naltrexone can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The metabolism of Naltrexone can be increased when combined with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Naltrexone can be increased when combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Naltrexone can be increased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Naltrexone can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Naltrexone can be increased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Naltrexone can be increased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Naltrexone can be increased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Naltrexone can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "The metabolism of Naltrexone can be increased when combined with Testosterone propionate"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Naltrexone may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of serotonin syndrome can be increased when Citalopram is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of serotonin syndrome can be increased when Duloxetine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "Pseudoephedrine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Methylenedioxyethamphetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may increase the analgesic activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of adverse effects can be increased when Trospium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of adverse effects can be increased when Benzatropine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of adverse effects can be increased when Disopyramide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of adverse effects can be increased when Ipratropium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of adverse effects can be increased when Metixene is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of adverse effects can be increased when Terfenadine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of adverse effects can be increased when Buclizine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of adverse effects can be increased when Clozapine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of adverse effects can be increased when Doxylamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of adverse effects can be increased when Procyclidine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The risk or severity of adverse effects can be increased when Profenamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of adverse effects can be increased when Darifenacin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of adverse effects can be increased when Atropine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of adverse effects can be increased when Nicardipine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "The risk or severity of adverse effects can be increased when Mecamylamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of adverse effects can be increased when Pirenzepine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Scopolamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of adverse effects can be increased when Benzquinamide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of adverse effects can be increased when Propiomazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of adverse effects can be increased when Propantheline is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of adverse effects can be increased when Dicyclomine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of adverse effects can be increased when Biperiden is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Brompheniramine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of adverse effects can be increased when Quinidine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of adverse effects can be increased when Methantheline is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of adverse effects can be increased when Cycrimine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Desloratadine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of adverse effects can be increased when Tolterodine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of adverse effects can be increased when Oxybutynin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "The risk or severity of adverse effects can be increased when Pentolinium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The risk or severity of adverse effects can be increased when Trimethaphan is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of adverse effects can be increased when Flavoxate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of adverse effects can be increased when Diphenidol is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Fenoterol is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Amobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Aprobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Butobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Heptabarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Hexobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of adverse effects can be increased when Tiotropium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Barbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01496",
                        "description": "The risk or severity of adverse effects can be increased when Dihydro 2 thioxo 5 5 2 trifluoromethyl phenyl 2 furanyl methyl 4 6 1H 5H pyrimidinedione is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of adverse effects can be increased when Solifenacin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of adverse effects can be increased when Isopropamide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of adverse effects can be increased when Mepenzolate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of adverse effects can be increased when Fesoterodine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of adverse effects can be increased when Hexocyclium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of adverse effects can be increased when Dimetindene is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of adverse effects can be increased when Agmatine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of adverse effects can be increased when Aclidinium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of adverse effects can be increased when Dexetimide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Benactyzine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of adverse effects can be increased when Umeclidinium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of adverse effects can be increased when Trimebutine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of adverse effects can be increased when Imidafenacin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of adverse effects can be increased when Thonzylamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of adverse effects can be increased when Methscopolamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The risk or severity of adverse effects can be increased when Revefenacin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of adverse effects can be increased when Oxitropium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of adverse effects can be increased when Propiverine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of adverse effects can be increased when Batefenterol is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of adverse effects can be increased when Tropatepine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of adverse effects can be increased when Prifinium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of adverse effects can be increased when Piperidolate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of adverse effects can be increased when Benzilone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of adverse effects can be increased when Difemerine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of adverse effects can be increased when Phenglutarimide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of adverse effects can be increased when Mazaticol is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of adverse effects can be increased when Otilonium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Emepronium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of adverse effects can be increased when Poldine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of adverse effects can be increased when Bevonium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of adverse effects can be increased when Rociverine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of adverse effects can be increased when Bornaprine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of adverse effects can be increased when Etanautine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of adverse effects can be increased when Tiemonium iodide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of adverse effects can be increased when Dihexyverine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of adverse effects can be increased when Penthienate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of adverse effects can be increased when Diphemanil is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of adverse effects can be increased when Camylofin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of adverse effects can be increased when Emetonium iodide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of adverse effects can be increased when Pipenzolate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of adverse effects can be increased when Timepidium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Triflupromazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when Promethazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Ziprasidone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of adverse effects can be increased when Imipramine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of adverse effects can be increased when Nortriptyline is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of adverse effects can be increased when Amoxapine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Procaine"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Amantadine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Doxepin"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Cisatracurium"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Phenobarbital is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of adverse effects can be increased when Amitriptyline is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thioridazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Moricizine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Trifluoperazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Periciazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Acepromazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Aceprometazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thioproperazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when BL 1020 is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Propiopromazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Perazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Butaperazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Chlorproethazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thiazinam is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Dixyrazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Perphenazine enanthate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Naltrexone may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The bioavailability of Naltrexone can be decreased when combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "The therapeutic efficacy of Zinc can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Sorbitol can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The therapeutic efficacy of Dantron can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The therapeutic efficacy of Prucalopride can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The therapeutic efficacy of Emodin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The therapeutic efficacy of Linaclotide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The therapeutic efficacy of Magnesium trisilicate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09409",
                        "description": "The therapeutic efficacy of Magnesium acetate tetrahydrate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09483",
                        "description": "The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The therapeutic efficacy of Mineral oil can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11089",
                        "description": "The therapeutic efficacy of Docusate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The therapeutic efficacy of Plantago seed can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The therapeutic efficacy of Castor oil can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The therapeutic efficacy of Sennosides can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The therapeutic efficacy of Plecanatide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13180",
                        "description": "The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13996",
                        "description": "The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The therapeutic efficacy of Magnesium can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The therapeutic efficacy of Alloin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leuprolide is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00052",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Somatotropin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Infliximab is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Daptomycin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cyclosporine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pravastatin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Baclofen is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sildenafil is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lovastatin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cladribine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pamidronic acid is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mefloquine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Carbimazole is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cerivastatin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Trimethoprim is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Betamethasone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Montelukast is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cimetidine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lercanidipine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ciprofloxacin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Vincristine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Propylthiouracil is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methotrexate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Enalapril is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nizatidine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ivermectin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Chloroquine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triamcinolone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Niacin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Alendronic acid is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Clofibrate is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Simvastatin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Stavudine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00666",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Amphotericin B is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mycophenolate mofetil is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Lamivudine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ibandronate"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Risedronic acid"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Bumetanide"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Isotretinoin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ganciclovir"
                    },
                    {
                        "drugbank-id": "DB01006",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Letrozole"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Minocycline"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Atorvastatin"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Captopril"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB06693",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Pitavastatin"
                    },
                    {
                        "drugbank-id": "DB08983",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Etofibrate"
                    },
                    {
                        "drugbank-id": "DB09055",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Acipimox"
                    },
                    {
                        "drugbank-id": "DB09064",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ciprofibrate"
                    },
                    {
                        "drugbank-id": "DB09270",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ipecac"
                    },
                    {
                        "drugbank-id": "DB13393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Emetine"
                    },
                    {
                        "drugbank-id": "DB13433",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Simfibrate"
                    },
                    {
                        "drugbank-id": "DB13460",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ronifibrate"
                    },
                    {
                        "drugbank-id": "DB13780",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Aluminium clofibrate"
                    },
                    {
                        "drugbank-id": "DB13849",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Clofibride"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Fenofibric acid"
                    },
                    {
                        "drugbank-id": "DB00173",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Adenine"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Indinavir"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Dasabuvir"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Sodium aurothiomalate"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Ombitasvir"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Paritaprevir"
                    },
                    {
                        "drugbank-id": "DB09298",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Silibinin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Naltrexone can be decreased when combined with Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tryptophan is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of serotonin syndrome can be increased when Eletriptan is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cabergoline is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of serotonin syndrome can be increased when Protriptyline is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of serotonin syndrome can be increased when Loxapine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of serotonin syndrome can be increased when Mazindol is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lisuride is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cisapride is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of serotonin syndrome can be increased when Furazolidone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of serotonin syndrome can be increased when Sumatriptan is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergotamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Apomorphine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Risperidone"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Methylthioninium"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB00504",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Levallorphan"
                    },
                    {
                        "drugbank-id": "DB01548",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Diprenorphine"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Nalmefene"
                    },
                    {
                        "drugbank-id": "DB11490",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Nalorphine"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Naldemedine"
                    },
                    {
                        "drugbank-id": "DB12013",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Axelopran"
                    },
                    {
                        "drugbank-id": "DB12341",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with LY 2456302"
                    },
                    {
                        "drugbank-id": "DB12543",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Samidorphan"
                    },
                    {
                        "drugbank-id": "DB12585",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Ondelopran"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "The therapeutic efficacy of Naltrexone can be decreased when used in combination with Naloxone"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The therapeutic efficacy of Naltrexone can be increased when used in combination with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Temazepam"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Alprazolam"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Chlordiazepoxide"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Adinazolam"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Clorazepic acid"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Midazolam"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Flurazepam"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Halazepam"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Oxazepam"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The risk or severity of adverse effects can be increased when Ethanol is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of constipation can be increased when Naltrexone is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Chlorzoxazone"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Meprobamate"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Carisoprodol"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Methocarbamol"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Metaxalone"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Tizanidine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Donepezil"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of respiratory depression can be increased when Naltrexone is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The therapeutic efficacy of Torasemide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "The therapeutic efficacy of Ethoxzolamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The therapeutic efficacy of Triamterene can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The therapeutic efficacy of Metolazone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The therapeutic efficacy of Amiloride can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Cyclothiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The therapeutic efficacy of Furosemide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The therapeutic efficacy of Eplerenone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The therapeutic efficacy of Methazolamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The therapeutic efficacy of Mannitol can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The therapeutic efficacy of Indapamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The therapeutic efficacy of Conivaptan can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The therapeutic efficacy of Zonisamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "The therapeutic efficacy of Diazoxide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The therapeutic efficacy of Diclofenamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Polythiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "The therapeutic efficacy of Quinethazone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The therapeutic efficacy of Drospirenone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The therapeutic efficacy of Theobromine can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The therapeutic efficacy of Piretanide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "The therapeutic efficacy of Ularitide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The therapeutic efficacy of Indisulam can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The therapeutic efficacy of Azosemide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "The therapeutic efficacy of Canrenoic acid can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The therapeutic efficacy of Efonidipine can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "The therapeutic efficacy of Mersalyl can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The therapeutic efficacy of Isosorbide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "The therapeutic efficacy of Canrenone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "The therapeutic efficacy of Rolofylline can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "The therapeutic efficacy of Spiradoline can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The therapeutic efficacy of Cicletanine can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "The therapeutic efficacy of Meticrane can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "The therapeutic efficacy of Mefruside can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Mebutizide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "The therapeutic efficacy of Clorexolone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "The therapeutic efficacy of Clofenamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "The therapeutic efficacy of Fenquizone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "The therapeutic efficacy of Clopamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "The therapeutic efficacy of Muzolimine can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "The therapeutic efficacy of Xipamide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "The therapeutic efficacy of Epitizide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The therapeutic efficacy of Bromotheophylline can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "The therapeutic efficacy of Potassium can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "The therapeutic efficacy of Potassium cation can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "Naphazoline may increase the central nervous system depressant CNS depressant activities of Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB11653",
                        "description": "The serum concentration of Naltrexone can be decreased when it is combined with Bremelanotide"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "Naltrexone can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of hypotension can be increased when Naltrexone is combined with Clonidine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fluoxetine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "Naltrexone can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}